Report AMR

About AMR

The usage of antimicrobials causes bacteria or pathogens to change over time and makes antimicrobial pharmaceuticals less effective. This process is called antimicrobial resistance (AMR).

When AMR infections occur and antimicrobials become ineffective, these infections can in the worst cases be fatal. In Japan and overseas, more and more microbes are developing AMR. If the current situation continues unabated, the annual number of deaths due to AMR infections is projected to increase to about 10 million people globally by 2050.

HGPI issued calls for action on this issue and AMR Alliance Japan was established in November 2018 with the goal of driving discussions and promoting policies for AMR with representatives from industry, Government, academia, and civil society. In its role as secretariat of AMR Alliance Japan, HGPI works to formulate policy recommendations and to see those recommendations implemented.

[In the Media] Commencement of the 109th HGPI Seminar “The Clinical Treatment of Infectious Diseases in Small Animals Today and in the Future” (mVm、March 1 2023)
2023-03-09

[In the Media] Commencement of the 109th HGPI Seminar “The Clinical Treatment of Infecti ...>>

[Event Report] HGPI Manager Attends “Universal Health Coverage (UHC) in an Era of Antimicrobial Resistance (AMR) and Pandemics” (February 21-22, 2023)
2023-03-09

[Event Report] HGPI Manager Attends “Universal Health Coverage (UHC) in an Era of Antimi ...>>

[Event Report] HGPI Special Seminar – Universal Health Coverage in an Era of Antimicrobial Resistance (August 18, 2022)
2023-03-09

[Event Report] HGPI Special Seminar – Universal Health Coverage in an Era of Antimicrobi ...>>

[Registration Closed] (Webinar) HGPI-Supported: Youth Engagement Seminar on Antimicrobial Resistance – lessons from global perspective by Dame Sally Davies, UK Special Envoy on AMR – (February 27, 2023)
2023-02-21

[Registration Closed] (Webinar) HGPI-Supported: Youth Engagement Seminar on Antimicrobia ...>>

[Activity Report] HGPI Submits Requests for the G7 Hiroshima Summit to the G7 Sous-Sherpa (December 23, 2022)
2023-02-02

[Activity Report] HGPI Submits Requests for the G7 Hiroshima Summit to the G7 Sous-Sherp ...>>

[Event Report] The 49th Special Breakfast Meeting – Push and Pull Incentives to Address AMR: The Experience of CARB-X and the potential for Public-Private Partnerships in Global Health (September 21, 2022)
2023-01-31

[Event Report] The 49th Special Breakfast Meeting – Push and Pull Incentives to Ad ...>>

[Recommendations] The Political Leadership and International Collaboration Needed to Advance Antimicrobial Resistance (AMR) Countermeasures (December 19, 2022)
2023-01-26

[Recommendations] The Political Leadership and International Collaboration Needed to Adv ...>>

[Activity Report] Opinions Regarding the Proposed “Action Policy for Ensuring a Stable Supply of Antimicrobial Substances” (December 23, 2022)
2023-01-24

[Activity Report] Opinions Regarding the Proposed “Action Policy for Ensuring a Stable S ...>>

[Activity Report] “AMR & JAPAN’S G7 PRESIDENCY: A Call for Pull Incentives to Drive Innovation” (December 13, 2022)
2023-01-23

[Activity Report] “AMR & JAPAN’S G7 PRESIDENCY: A Call for Pull Incentives to Drive ...>>

[In the Media] Commencement of the 109th HGPI Seminar “The Clinical Treatment of Infectious Diseases in Small Animals Today and in the Future” (Farm Press, January 16, 2023)
2023-01-23

[In the Media] Commencement of the 109th HGPI Seminar “The Clinical Treatment of Infecti ...>>

[Event Report] The 109th HGPI Seminar “The Clinical Treatment of Infectious Diseases in Small Animals Today and in the Future – Current Circumstances for AMR Control and Emerging Infectious Diseases in Companion Animals” (December 9, 2022)
2023-01-18

[Event Report] The 109th HGPI Seminar “The Clinical Treatment of Infectious Diseases in ...>>

[In the Media] The 9th NIKKEI FT Communicable Diseases Conference – Antibiotic Development “Considering the Introduction of a National Guarantee System” (Nikkei Inc., November 16)
2022-12-05

[In the Media] The 9th NIKKEI FT Communicable Diseases Conference – Antibiotic Developme ...>>

PageTop